Inhalon Biopharma is a bio-tech company which is into research & development of monoclonal antibodies.
Inhalon Biopharma has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in November 2022.
Inhalon Biopharma's investors include Berkeley Catalyst Fund (BCF), Sand Hill Angels, Life Science Angels, Collaboratory, U.S. Army Medical Research & Development Command.
Inhalon Biopharma is headquartered in Carrboro, United States.
Inhalon Biopharma is a bio-tech company which is into research & development of monoclonal antibodies.
Inhalon Biopharma is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inhalon Biopharma — Funding & Investors." VCBacked, November 8, 2022, https://www.vcbacked.co/company/inhalon-biopharma. Accessed November 14, 2026.
VCBacked. (2022). Inhalon Biopharma — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/inhalon-biopharma
{{cite web |title=Inhalon Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/inhalon-biopharma |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Inhalon Biopharma? Request a listing update